Relationship between bone turnover markers and oxidative stress in children with type 1 diabetes mellitus

Doaa El Amrousy1, Dalia El-Afify2, Ahmed Shabana3

  • 1Pediatric Department, Faculty of Medicine, Tanta University, Tanta, Egypt. doaamoha@yahoo.com.

Pediatric Research
|October 10, 2020
PubMed

Insights

Oxidative stress is linked to altered bone turnover in children with type 1 diabetes mellitus (T1DM). Lower bone formation and higher bone breakdown markers were observed in T1DM patients, correlating with oxidative stress indicators.

Area of Science:

  • Pediatric Endocrinology
  • Bone Metabolism
  • Oxidative Stress Research

Background:

  • Oxidative stress may negatively impact bone health in children with type 1 diabetes mellitus (T1DM).
  • The specific relationship between oxidative stress and bone turnover in pediatric T1DM remains understudied.

Purpose of the Study:

  • To investigate the association between oxidative stress markers and bone turnover markers in children with T1DM.
  • To determine if oxidative stress influences bone metabolism in pediatric patients with T1DM.

Main Methods:

  • Compared 40 children with T1DM to 40 healthy controls matched for age and sex.
  • Measured plasma bone turnover markers (alkaline phosphatase, procollagen type-1 amino-terminal propeptide [P1NP], urinary deoxypyridinoline [DPD]) and oxidative stress markers (glutathione, superoxide dismutase [SOD], malondialdehyde [MDA]).

Main Results:

  • Children with T1DM exhibited lower P1NP and higher DPD levels, indicating altered bone turnover.
  • T1DM patients showed reduced glutathione and SOD, and elevated MDA, signifying increased oxidative stress.
  • Significant correlations were found between bone turnover markers and oxidative stress markers, with glutathione and MDA predicting P1NP and DPD levels.

Conclusions:

  • An association exists between oxidative stress and bone turnover markers in children with T1DM.
  • Increased oxidative stress may impair bone turnover in pediatric T1DM, suggesting therapeutic strategies targeting glycemic control and oxidative stress reduction could benefit bone health.
Abstract